Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment.
cancer associated fibroblast activation
cancer progression
chemoresistance
collagen type XI alpha 1
epithelial ovarian cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
04
2022
accepted:
31
05
2022
entrez:
18
7
2022
pubmed:
19
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
The extracellular matrix (ECM) plays an important role in the progression of cancer. Collagen is the most abundant component in ECM, and is involved in the biological formation of cancer. Although type XI collagen is a minor fibrillar collagen, collagen XI alpha 1 chain (COL11A1) expression has been found to be upregulated in a variety of human cancers including colorectal, esophagus, glioma, gastric, head and neck, lung, ovarian, pancreatic, salivary gland, and renal cancers. High levels of COL11A1 usually predict poor prognosis, owing to its association with angiogenesis, invasion, and drug resistance in cancer. However, little is known about the specific mechanism through which COL11A1 regulates tumor progression. Here, we have organized and summarized recent developments regarding the interactions between COL11A1 and intracellular signaling pathways and selected therapeutic agents targeting COL11A1, as these indicate its potential as a target for treatment of cancers, especially epithelial ovarian cancer.
Identifiants
pubmed: 35847935
doi: 10.3389/fonc.2022.925165
pmc: PMC9277861
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
925165Informations de copyright
Copyright © 2022 Wu and Chou.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Oncol Rep. 2016 Aug;36(2):877-85
pubmed: 27373316
Trends Biotechnol. 2015 Apr;33(4):230-6
pubmed: 25708906
J Invest Surg. 2021 Jun;34(6):664-669
pubmed: 33148075
In Vitro Cell Dev Biol Anim. 2014 Apr;50(4):358-66
pubmed: 24092017
J Cancer. 2015 Aug 22;6(10):1011-9
pubmed: 26366215
Cancer Metastasis Rev. 2009 Jun;28(1-2):113-27
pubmed: 19153673
J Cell Physiol. 2018 Aug;233(8):6280-6290
pubmed: 29521413
Curr Biol. 1997 Oct 1;7(10):776-89
pubmed: 9368760
Cell. 2006 Oct 6;127(1):125-37
pubmed: 16962653
J Biol Chem. 2003 Aug 29;278(35):32763-70
pubmed: 12805369
Cancer Lett. 2016 Nov 28;382(2):203-214
pubmed: 27609069
Mol Endocrinol. 2015 Jun;29(6):921-32
pubmed: 25866874
Cancers (Basel). 2018 Aug 07;10(8):
pubmed: 30087253
Tumour Biol. 2015 Apr;36(4):2213-22
pubmed: 25761876
J Biol Chem. 2017 Dec 8;292(49):20076-20085
pubmed: 29025875
Cancers (Basel). 2020 Aug 31;12(9):
pubmed: 32878206
Cell Stem Cell. 2011 Nov 4;9(5):402-11
pubmed: 22056138
Cancers (Basel). 2021 Feb 24;13(5):
pubmed: 33668097
Cancer Res. 2003 Nov 1;63(21):7081-8
pubmed: 14612499
Int J Radiat Biol. 2021;97(7):958-967
pubmed: 33970764
Cells. 2020 Jul 22;9(8):
pubmed: 32707902
Oncotarget. 2015 Sep 15;6(27):23748-63
pubmed: 26087191
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7160-5
pubmed: 21474781
Clin Transl Gastroenterol. 2019 Jul;10(7):e00056
pubmed: 31295152
J Biol Chem. 2000 Apr 7;275(14):10370-8
pubmed: 10744725
Cancer Biol Ther. 2018 May 4;19(5):364-372
pubmed: 29333916
Carcinogenesis. 2001 Jun;22(6):875-8
pubmed: 11375892
Nat Rev Cancer. 2002 Jul;2(7):489-501
pubmed: 12094235
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Oncogenesis. 2017 Jul 3;6(7):e352
pubmed: 28671675
Cancer Res. 2006 Mar 15;66(6):3126-36
pubmed: 16540663
Cancer Cell Int. 2020 Jan 10;20:13
pubmed: 31938021
J Vasc Surg. 2011 May;53(5):1341-1349.e3
pubmed: 21334170
J Cell Biol. 1986 Jul;103(1):223-9
pubmed: 3722264
Mol Pharmacol. 2007 Jul;72(1):152-61
pubmed: 17400764
Int J Cancer. 2017 Dec 1;141(11):2305-2317
pubmed: 28815582
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Oncol Rep. 2006 Nov;16(5):981-8
pubmed: 17016581
Gynecol Oncol. 2006 Aug;102(2):348-55
pubmed: 16545436
Math Biosci Eng. 2019 Nov 27;17(2):1428-1441
pubmed: 32233587
Oncotarget. 2017 Oct 4;8(61):103509-103517
pubmed: 29262580
Reprod Biol Endocrinol. 2003 Oct 07;1:66
pubmed: 14609433
BMC Cancer. 2014 Nov 23;14:867
pubmed: 25417197
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):10983-5
pubmed: 11572954
J Transl Med. 2019 Sep 14;17(1):309
pubmed: 31521169
Cancer Lett. 2018 Jan 1;412:155-169
pubmed: 29079415
Int J Clin Exp Pathol. 2015 Jan 01;8(1):517-29
pubmed: 25755742
J Exp Clin Cancer Res. 2019 Mar 6;38(1):115
pubmed: 30841909
Front Pharmacol. 2020 Mar 03;11:206
pubmed: 32194423
Int J Mol Sci. 2017 May 27;18(6):
pubmed: 28555007
Cell Signal. 2002 May;14(5):381-95
pubmed: 11882383
Cancer. 2016 Feb 15;122(4):588-597
pubmed: 26566079
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a004978
pubmed: 21421911
J Proteome Res. 2009 Jun;8(6):2873-81
pubmed: 19351187
Oncogene. 2014 Jun 26;33(26):3432-40
pubmed: 23934190
Ann Transl Med. 2021 Oct;9(20):1577
pubmed: 34790783
Cell Death Dis. 2019 Apr 11;10(4):322
pubmed: 30975980
Mol Med Rep. 2020 Nov;22(5):3677-3686
pubmed: 32901847
Clin Cancer Res. 2014 Feb 1;20(3):711-23
pubmed: 24218511
Oncogene. 2018 Aug;37(35):4809-4820
pubmed: 29769618
Cancer Discov. 2018 Mar;8(3):304-319
pubmed: 29196464
Curr Biol. 1997 Apr 1;7(4):261-9
pubmed: 9094314
Theranostics. 2018 Oct 6;8(18):5072-5087
pubmed: 30429887
Semin Cancer Biol. 2019 Dec;59:147-160
pubmed: 31128298
J Biol Chem. 2010 Jun 18;285(25):19647-59
pubmed: 20404328
Cell. 2002 Nov 1;111(3):293-303
pubmed: 12419241
In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):235-42
pubmed: 26487428
J Cancer. 2021 Jan 1;12(5):1406-1420
pubmed: 33531986
Mol Carcinog. 2015 Nov;54(11):1301-14
pubmed: 25154814
Nat Rev Cancer. 2009 Feb;9(2):108-22
pubmed: 19165226
Mol Cell. 2006 Apr 21;22(2):159-68
pubmed: 16603397
Tumour Biol. 2017 Oct;39(10):1010428317718403
pubmed: 29025374
Int J Cancer. 2008 Feb 1;122(3):534-46
pubmed: 17918180
PLoS One. 2020 Mar 25;15(3):e0222259
pubmed: 32210440
Clin Cancer Res. 2020 Jun 15;26(12):2819-2826
pubmed: 31900279
Br J Cancer. 2014 Jan 7;110(1):123-32
pubmed: 24178762
Cancer Lett. 2015 Feb 28;357(2):448-53
pubmed: 25511741
PLoS One. 2013 Oct 23;8(10):e78327
pubmed: 24194920
Biochem J. 2000 Mar 15;346 Pt 3:561-76
pubmed: 10698680
Oncogene. 2021 Jul;40(26):4503-4519
pubmed: 34117361
Neuro Oncol. 2016 Aug;18(8):1146-56
pubmed: 26902851
Matrix Biol. 2020 Dec;94:77-94
pubmed: 32950601
J Clin Oncol. 2007 Mar 1;25(7):852-61
pubmed: 17327606
Mol Cancer. 2010 Apr 23;9:88
pubmed: 20416094
Clin Cancer Res. 2019 Nov 1;25(21):6417-6428
pubmed: 31332047
PLoS One. 2011;6(7):e21679
pubmed: 21799743
Cytokine. 2015 Mar;72(1):71-85
pubmed: 25622278
Histol Histopathol. 2015 Jan;30(1):87-93
pubmed: 25005174
Cell Death Dis. 2020 Apr 20;11(4):258
pubmed: 32312965
Cancers (Basel). 2021 Dec 13;13(24):
pubmed: 34944877
BMC Biol. 2017 Feb 13;15(1):9
pubmed: 28193224
Oncogene. 2010 Jan 7;29(1):11-25
pubmed: 19802016
Oncol Rep. 2017 Jan;37(1):333-340
pubmed: 28004111
Br J Cancer. 2013 Dec 10;109(12):3049-56
pubmed: 24231953
Exp Cell Res. 1999 Nov 25;253(1):210-29
pubmed: 10579924
Semin Cancer Biol. 2020 May;62:192-200
pubmed: 31518697
Gut. 2008 Oct;57(10):1420-30
pubmed: 18515410